Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2020 2
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
In Vitro/In Vivo Electrochemical Detection of Pt(II) Species.
Vaneev AN, Gorelkin PV, Krasnovskaya OO, Akasov RA, Spector DV, Lopatukhina EV, Timoshenko RV, Garanina AS, Zhang Y, Salikhov SV, Edwards CRW, Klyachko NL, Takahashi Y, Majouga AG, Korchev YE, Erofeev AS. Vaneev AN, et al. Among authors: lopatukhina ev. Anal Chem. 2022 Mar 29;94(12):4901-4905. doi: 10.1021/acs.analchem.2c00136. Epub 2022 Mar 14. Anal Chem. 2022. PMID: 35285614
Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug.
Krasnovskaya OO, Akasov RA, Spector DV, Pavlov KG, Bubley AA, Kuzmin VA, Kostyukov AA, Khaydukov EV, Lopatukhina EV, Semkina AS, Vlasova KY, Sypalov SA, Erofeev AS, Gorelkin PV, Vaneev AN, Nikitina VN, Skvortsov DA, Ipatova DA, Mazur DM, Zyk NV, Sakharov DA, Majouga AG, Beloglazkina EK. Krasnovskaya OO, et al. Among authors: lopatukhina ev. ACS Appl Mater Interfaces. 2023 Mar 15;15(10):12882-12894. doi: 10.1021/acsami.3c01771. Epub 2023 Feb 28. ACS Appl Mater Interfaces. 2023. PMID: 36854172
Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position.
Spector DV, Pavlov KG, Akasov RA, Vaneev AN, Erofeev AS, Gorelkin PV, Nikitina VN, Lopatukhina EV, Semkina AS, Vlasova KY, Skvortsov DA, Roznyatovsky VA, Ul'yanovskiy NV, Pikovskoi II, Sypalov SA, Garanina AS, Vodopyanov SS, Abakumov MA, Volodina YL, Markova AA, Petrova AS, Mazur DM, Sakharov DA, Zyk NV, Beloglazkina EK, Majouga AG, Krasnovskaya OO. Spector DV, et al. Among authors: lopatukhina ev. J Med Chem. 2022 Jun 23;65(12):8227-8244. doi: 10.1021/acs.jmedchem.1c02136. Epub 2022 Jun 8. J Med Chem. 2022. PMID: 35675651
Scanning Ion-Conductance Microscopy for Studying β-Amyloid Aggregate Formation on Living Cell Surfaces.
Kolmogorov VS, Erofeev AS, Barykin EP, Timoshenko RV, Lopatukhina EV, Kozin SA, Gorbacheva LR, Salikhov SV, Klyachko NL, Mitkevich VA, Edwards CRW, Korchev YE, Makarov AA, Gorelkin PV. Kolmogorov VS, et al. Among authors: lopatukhina ev. Anal Chem. 2023 Oct 31;95(43):15943-15949. doi: 10.1021/acs.analchem.3c02806. Epub 2023 Oct 19. Anal Chem. 2023. PMID: 37856787
Discovery of Bivalent GalNAc-Conjugated Betulin as a Potent ASGPR-Directed Agent against Hepatocellular Carcinoma.
Yamansarov EY, Lopatukhina EV, Evteev SA, Skvortsov DA, Lopukhov AV, Kovalev SV, Vaneev AN, Shkil' DO, Akasov RA, Lobov AN, Naumenko VA, Pavlova EN, Ryabaya OO, Burenina OY, Ivanenkov YA, Klyachko NL, Erofeev AS, Gorelkin PV, Beloglazkina EK, Majouga AG. Yamansarov EY, et al. Among authors: lopatukhina ev. Bioconjug Chem. 2021 Apr 21;32(4):763-781. doi: 10.1021/acs.bioconjchem.1c00042. Epub 2021 Mar 10. Bioconjug Chem. 2021. PMID: 33691403
New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.
Petrov RA, Mefedova SR, Yamansarov EY, Maklakova SY, Grishin DA, Lopatukhina EV, Burenina OY, Lopukhov AV, Kovalev SV, Timchenko YV, Ondar EE, Ivanenkov YA, Evteev SA, Vaneev AN, Timoshenko RV, Klyachko NL, Erofeev AS, Gorelkin PV, Beloglazkina EK, Majouga AG. Petrov RA, et al. Among authors: lopatukhina ev. Mol Pharm. 2021 Jan 4;18(1):461-468. doi: 10.1021/acs.molpharmaceut.0c00980. Epub 2020 Dec 2. Mol Pharm. 2021. PMID: 33264010
Synthesis and Evaluation of New Trivalent Ligands for Hepatocyte Targeting via the Asialoglycoprotein Receptor.
Reshitko GS, Yamansarov EY, Evteev SA, Lopatukhina EV, Shkil' DO, Saltykova IV, Lopukhov AV, Kovalev SV, Lobov AN, Kislyakov IV, Burenina OY, Klyachko NL, Garanina AS, Dontsova OA, Ivanenkov YA, Erofeev AS, Gorelkin PV, Beloglazkina EK, Majouga AG. Reshitko GS, et al. Among authors: lopatukhina ev. Bioconjug Chem. 2020 May 20;31(5):1313-1319. doi: 10.1021/acs.bioconjchem.0c00202. Epub 2020 May 9. Bioconjug Chem. 2020. PMID: 32379426